Company Description
Transphorm, Inc., a semiconductor company, develops, manufactures, and sells gallium nitride (GaN) semiconductor components for high voltage power conversion applications in Mainland China, Hong Kong, Taiwan, the United States, Japan, South Korea, India, and Europe.
The company's products include GaN field effect transistors in various packages. Its GaN devices allows customers to design power systems creating functional value in various end products, including smartphone power adapters/fast-chargers, power supplies for datacenter servers/communication, industrial power converters, chargers/converters/inverters for electric vehicles, and other applications.
The company offers its products through regional distributors and sales representatives. Transphorm, Inc. was founded in 2007 and is headquartered in Goleta, California.
Country | United States |
Founded | 2007 |
Industry | Semiconductor Equipment & Materials |
Sector | Technology |
Employees | 128 |
CEO | Dr. Primit A. Parikh Ph.D. |
Contact Details
Address: 75 Castilian Drive Goleta, California 93117 United States | |
Phone | 805-456-1300 |
Website | transphormusa.com |
Stock Details
Ticker Symbol | TGAN |
Exchange | NASDAQ |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001715768 |
CUSIP Number | 89386L100 |
ISIN Number | US89386L1008 |
Employer ID | 82-1858829 |
SIC Code | 3674 |
Key Executives
Name | Position |
---|---|
Dr. Primit A. Parikh Ph.D. | Co-Founder, President, Chief Executive Officer and Director |
Cameron McAulay | Chief Financial Officer |
Dr. Umesh K. Mishra Ph.D. | Chairman and Chief Technology Officer |
Philip Zuk | Senior Vice President of Business Development and Marketing |
Tushar Dhayagude | Vice President of Worldwide Sales and FAE |
Randy Berg | Human Resources Leader |
Sal Barlett | Senior Vice President of Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 10, 2024 | 8-K | Current Report |
Apr 5, 2024 | 144 | Filing |
Mar 5, 2024 | 8-K | Current Report |
Mar 4, 2024 | DEFM14A | Filing |
Mar 1, 2024 | 144 | Filing |
Feb 28, 2024 | 144 | Filing |
Feb 28, 2024 | 144 | Filing |
Feb 23, 2024 | PREM14A | Filing |
Feb 20, 2024 | 10-Q | Quarterly Report |
Feb 20, 2024 | 8-K | Current Report |